Larry Merlo joins Kimberly-Clark's board as the company reshapes its portfolio

Larry Merlo spent nearly a decade as the chief executive of CVS Health, building one of the largest retail pharmacy and healthcare distribution networks in the United States. That operational background now arrives at a $66.8 billion consumer staples company in the middle of a significant strategic overhaul.

Kimberly-Clark is executing what it calls its Powering Care transformation, a push to reshape its product portfolio toward higher-value growth categories. Adding a director with Merlo's scale of experience running a consumer-facing, distribution-intensive enterprise is a signal that the board wants that kind of perspective in the room as the company navigates that shift.

The appointment took effect November 4, 2026, adding Merlo in a director capacity rather than an executive role. His influence will be felt through board-level decisions on strategy, capital allocation, and the pace of the portfolio transition rather than day-to-day operations.

For investors already watching how Powering Care plays out, Merlo's arrival signals where the board's strategic priorities are headed. A director with deep retail and healthcare distribution roots will shape how aggressively Kimberly-Clark moves into adjacent higher-margin product lines.